Not signed in (Sign In)
Monaslim Rimonabant - Generic Acomplia Tablets

Social Bookmarks

    • CommentAuthordcindy68
    • CommentTimeApr 29th 2008
     
    Is rimonabant (Acomplia/Zimulti/Slimona/Monaslim) a diet or an anti-smoking drug?
    • CommentAuthorElizabeth
    • CommentTimeApr 29th 2008
     
    Rimonabant is a diet drug developed by Sanofi-Synthelabo Inc. and marketed as Acomplia in the UK since June 2006 and other countries shortly after. It is sometimes used to help reduce smoking, but that form of use has not been approved of in all countries of sale.
    • CommentAuthorNikkifinn
    • CommentTimeApr 29th 2008
     
    Rimonabant is a selective CB1 blocker that act on the endocannabinoid (EC) system of the human body. An over-stimulated EC system is thought to play a role in obesity and in tobacco dependence, therefore these CB1 blockers are supposed to reduce this over stimulation.

    These medications are still not in wide use worldwide and are quite new in relation to other medications. Time will tell how CB1 blockers are tolerated by people now that it is becoming more widely available.

    Few drugs are widely approved for long-treatment of obesity. These include the lipase inhibitor orlistat and the drug sibutramine. As with most medications, each of these products has been limited by their side effects.

    Searches related to rimonabant:

    • zimulti
    • chantix
    • sibutramine
    • accomplia
    • orlistat
    • diabetes
Add your comments
    Please enter the following code:
  • Format comments as